Drug development is one of the highest-stakes place for AI to drive meaningful outcomes for people. Mike joining Formation Bio, given his track record in pharma, is real world proof of that thesis. In the AI era, expert judgment matters more, not less. Excited for him to bring his expertise and scientific leadership to the team at Formation.
Excited to share that Mike Ehlers is joining @formationbio as Chief Scientific Officer and Head of R&D. Over the course of his career as a scientist, drug developer, and investor, Mike has advanced 40+ drugs into the clinic, with approvals spanning Alzheimer's, ALS, MS, hemophilia, and SMA. Welcome to the team, Mike!
@skupor @formationbio Thanks for sharing your disclosure in a way that actually feels honest and authentic. ;)